Pharmaceuticals

Pharmaceutical Stability And Storage Services Market to Grow at a CAGR of 6.1% from 2025 to 2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Future Market Size Estimation For The Pharmaceutical Stability And Storage Services Market Covering 2025–2034?

The pharmaceutical stability and storage services market has shown robust expansion in recent years. Its valuation is anticipated to climb from $2.66 billion in 2024 to $2.81 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.8%. The expansion observed in past periods is attributable to several key factors, including the escalating demand for biologics, the rising incidence of chronic diseases, advancements in drug development, the increasing intricacy of drug formulations, and intensified research and development activities within the pharmaceutical industry.

The market for pharmaceutical stability and storage services is projected to experience substantial expansion in the coming years. This market is set to reach a size of $3.57 billion by 2029, achieving a compound annual growth rate (CAGR) of 6.1%. The anticipated growth during this forecast period stems from factors such as the rise of personalized medicine, an increase in cold chain logistics, the expansion of biopharma pipelines, a surge in biologic drug approvals, and an escalating need for stability testing. Key trends identified for the forecast period encompass general technological advancements, progress in cryogenic storage solutions, the evolution of digital monitoring technologies, the creation of innovative packaging methods, and sophisticated temperature-controlled storage systems.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=23473&type=smp

Which Major Market Drivers Are Shaping The Future Of The Pharmaceutical Stability And Storage Services Market?

The rising volume of novel drug approvals is anticipated to fuel the expansion of the pharmaceutical stability and storage services market in the future. A novel drug is defined as a recently developed pharmaceutical compound that has not received prior approval for application or commercialization. This increase in novel drug approvals stems from progress in biotechnology, which allows for the identification of new compounds, alongside enhanced regulatory procedures that streamline drug development, making it quicker and more effective. The growing number of novel drug approvals boosts the need for pharmaceutical stability and storage services, which are crucial for maintaining ideal conditions, ensuring adherence to regulations, and managing extended shelf life. For example, data from October 2023, provided by the U.S. Food and Drug Administration (FDA), a U.S.-based federal agency responsible for protecting public health, indicated that in 2022, the FDA approved 37 novel drugs, with 50 approvals in 2024, thereby advancing treatments for cancer, rare diseases, neurology, infections, and conditions like schizophrenia, pain, and Alzheimer’s. Consequently, the expanding volume of novel drug approvals stimulates the growth of the pharmaceutical stability and storage services market.

What Are The Major Segment Categories Driving The Pharmaceutical Stability And Storage Services Market Growth?

The pharmaceutical stability and storage services market covered in this report is segmented –

1) By Service: Stability, Storage

2) By Product Type: Tablets, Capsules, Injectable Solutions, Oral Suspensions, Combination Products, Other Product Types

3) By Molecule: Small Molecule, Large Molecule

4) By Mode: In-House, Outsourcing

5) By End User: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Other End Users

Subsegments:

1) Stability Services: Long-Term Stability Studies, Accelerated Stability Studies, Intermediate Stability Studies, Photostability Testing, Forced Degradation Studies

2) Storage Services: Ambient Storage, Refrigerated Storage (2°C to 8°C), Frozen Storage (-20°C to -80°C), Cryogenic Storage (-150°C to -196°C), Controlled Drug Substance And Product Storage

Which Key Trends Are Expected To Influence The Pharmaceutical Stability And Storage Services Market In The Coming Years?

Major companies within the pharmaceutical stability and storage services market are concentrating on developing technologically advanced solutions, such as cryogenic storage suites, to enhance the preservation of temperature-sensitive pharmaceutical products. Cryogenic storage suites are specialized facilities that maintain extremely low temperatures, typically below -150°C, for safeguarding delicate biological and pharmaceutical materials like cell therapies, vaccines, and biologics. For instance, in December 2024, Astoriom, a UK-based company specializing in stability and biospecimen storage, launched a cryogenic storage suite at its Tramore facility in County Waterford, Ireland, signifying a major expansion in its capabilities for biological sample storage. This cutting-edge suite is designed to meet the increasing demand for safe, long-term preservation of biological materials, ensuring their viability over extended periods. This storage solution offers precise temperature control down to -196°C, extensive storage capacity, ISO 9001 certification for regulatory compliance, and sophisticated security measures, including access controls and monitoring systems.

Who Are The Major Companies Operating In The Pharmaceutical Stability And Storage Services Market?

Major companies operating in the pharmaceutical stability and storage services market are Cencora Inc, SGS S.A., Eurofins Scientific SE, Catalent Inc, Charles River Laboratories, Intertek Group plc, Element Materials Technology Inc, Alloga UK Ltd., ALS Limited, Pharmaceutical Contract Industries Pharma Services., Almac Group, Alcami Corporation, BioLife Solutions Inc., Auriga Research Private Limited, Reading Scientific Services Ltd., Lucideon Limited, Q Laboratories Inc, PD Partners, Precision Stability Storage, Roylance Stability Storage Limited

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/pharmaceutical-stability-and-storage-services-global-market-report

How Does The Pharmaceutical Stability And Storage Services Market Perform Across Key Geographic Regions?

North America was the largest region in the pharmaceutical stability and storage services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical stability and storage services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Pharmaceutical Stability And Storage Services Market Report:

https://www.thebusinessresearchcompany.com/customise?id=23473&type=smp

Browse Through More Reports Similar to the Global Pharmaceutical Stability And Storage Services Market 2025, By The Business Research Company

Storage And Warehouse Leasing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/storage-and-warehouse-leasing-global-market-report

Oil Storage Market 2025

https://www.thebusinessresearchcompany.com/report/oil-storage-market

External Storage Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/external-storage-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795